Small Particles, Big Impact: Revolutionising Drug Delivery

Overview

Imagine a future where medicines work better and cause fewer side effects. Join us to hear from pharmaceutical pioneer Professor Dame Ijeoma Uchegbu, President of Wolfson College, Cambridge, as she explores the future of medicine through nanotechnology.

Ijeoma and her team are developing groundbreaking nanoparticle technology that delivers drugs precisely where they’re needed in the body. It’s a fascinating breakthrough that anyone interested in technological innovation needs to hear more about.

The Challenge in Drug Development

What if we told you that for every successful medicine, 4,999 candidates fail? Drug development is a complex journey, with only 1 in 5,000 molecules making it from concept to market, at a cost of $1 billion per success. Even in clinical trials, 90% of drugs fall short, often because they can’t reach their target effectively.

Patient Challenges: A Call for Better Solutions

Ever wondered why half of patients with chronic conditions struggle with their medication? More often than not, it’s fear of unwanted side effects that holds them back. But what if we could direct medicines to focus on diseased areas while sparing healthy tissue?

A Breakthrough Approach

This is where the story gets astonishing. Scientists are developing nanoparticles – tiny carriers just a thousandth the width of a human hair – that can guide medicines to where they’re needed most.  Professor Uchegbu’s flagship development, Envelta™, represents a breakthrough in pain management. As a non-addictive alternative to opioids, it addresses a critical need: every year, 80,000 Americans lose their lives to opioid poisoning, while in the UK, 40 families face such tragedy weekly.

Building on this success, her team’s research extends into cancer treatments and therapies for sight-threatening conditions, with new discoveries emerging through Nanomerics Ltd., recipient of the 2024 King’s Award for Enterprise for Innovation. Some of these potential therapies are in clinical trials. Join us as we explore the possibilities of this truly revolutionary approach to medicine.

About the Speaker

Professor Uchegbu is a pioneer in pharmaceutical nanoscience and a champion of scientific innovation. As UCL’s Professor of Pharmaceutical Nanoscience and Chief Scientific Officer of Nanomerics Ltd., she has successfully translated laboratory discoveries into clinical applications.

Practical Information

The talk includes a Q&A session.

Booking is essential. Lit & Phil members: we recommend logging into the website to make booking your free member ticket quicker and easier.